CRIS Current Research Information System

COLECCHIA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.425
EU - Europa 4.819
AS - Asia 4.229
AF - Africa 380
SA - Sud America 263
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.377
GB - Regno Unito 1.431
SG - Singapore 1.332
CN - Cina 1.287
VN - Vietnam 774
IT - Italia 680
DE - Germania 623
SE - Svezia 586
HK - Hong Kong 316
RU - Federazione Russa 285
IN - India 272
UA - Ucraina 257
FR - Francia 226
IE - Irlanda 195
BR - Brasile 174
ZA - Sudafrica 127
EE - Estonia 115
NL - Olanda 109
CI - Costa d'Avorio 102
CH - Svizzera 101
TG - Togo 65
JP - Giappone 62
JO - Giordania 54
FI - Finlandia 52
NG - Nigeria 39
KR - Corea 36
AR - Argentina 34
BG - Bulgaria 34
SC - Seychelles 34
CA - Canada 32
BE - Belgio 25
GR - Grecia 23
EC - Ecuador 20
PL - Polonia 19
IR - Iran 16
BD - Bangladesh 15
ES - Italia 15
MX - Messico 12
ID - Indonesia 11
LT - Lituania 10
LB - Libano 9
CO - Colombia 8
TR - Turchia 7
CL - Cile 6
HR - Croazia 6
AT - Austria 5
AU - Australia 5
CZ - Repubblica Ceca 5
PE - Perù 5
PK - Pakistan 5
PY - Paraguay 5
TW - Taiwan 5
VE - Venezuela 5
IL - Israele 4
KE - Kenya 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BO - Bolivia 3
DK - Danimarca 3
EG - Egitto 3
IQ - Iraq 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
KZ - Kazakistan 2
MD - Moldavia 2
MM - Myanmar 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
Totale 17.126
Salva come PNG Salva come JPEG
Città #
Southend 1.308
Fairfield 941
Singapore 837
Ashburn 750
Chandler 606
Woodbridge 397
Houston 370
Seattle 369
Wilmington 368
Santa Clara 339
Dong Ket 317
Hong Kong 310
Cambridge 290
Ann Arbor 276
Princeton 266
Beijing 206
Dublin 194
Boardman 164
Jacksonville 152
Nanjing 135
Westminster 127
Bologna 123
Padova 119
Hefei 109
Abidjan 102
Los Angeles 90
Bern 86
New York 77
Berlin 66
Frankfurt am Main 65
Lomé 65
Saint Petersburg 62
Ho Chi Minh City 59
Tokyo 59
Medford 57
San Diego 57
Buffalo 56
Amman 54
Dallas 54
Shenyang 53
Milan 52
Dearborn 51
Hanoi 48
Jinan 47
Helsinki 40
Abeokuta 39
Hebei 37
Seoul 34
Changsha 33
Sofia 33
Nanchang 32
Turin 32
Tianjin 31
Bremen 30
Munich 29
Redondo Beach 29
Jiaxing 26
Guangzhou 25
Mülheim 25
Shanghai 25
Brussels 22
Redwood City 22
Falkenstein 21
Florence 21
Mahé 20
Yubileyny 20
São Paulo 19
Norwalk 18
Des Moines 17
Hangzhou 17
Kuban 17
Ningbo 17
Toronto 17
Falls Church 16
Mountain View 16
Phoenix 14
Haikou 13
Chicago 12
Fuzhou 12
Pune 12
Rome 12
Taizhou 12
Zhengzhou 12
Brooklyn 11
Lanzhou 11
London 11
Taiyuan 11
Turku 11
Xi'an 11
Guayaquil 10
Haiphong 10
Kunming 10
Leawood 10
Monmouth Junction 10
Shenzhen 10
Torino 10
Verona 10
Wuhan 10
Olalla 9
Bengaluru 8
Totale 11.385
Salva come PNG Salva come JPEG
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 260
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 260
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 250
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 227
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 226
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 213
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 202
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 200
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 198
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 195
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 190
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 186
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 184
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 184
Benign hepatic nodular lesions after treatment for childhood cancer 181
H 2breath testing for other gas-related syndromes 179
null 179
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 176
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 172
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 170
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 166
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 160
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 159
Gut Microbiota and Celiac Disease 158
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 158
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 158
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 156
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 154
Pharmacological modulation of MRP2 in primary biliary cirrhosis 152
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 152
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 151
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 148
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 148
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 148
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 148
Biliary symptoms, gallbladder motility, and cholecystectomy 147
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 147
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 146
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 144
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 144
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 144
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 144
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 144
Breath tests with stable isotopes: have they a role in liver transplantation? 142
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 142
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 141
Safety of interferon beta treatment for chronic HCV hepatitis. 140
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 139
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 139
Calcolosi della colecisti complicata 137
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 137
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 137
Management of hepatic encephalopathy: focus on antibiotic therapy 137
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 136
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 134
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 133
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 132
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 132
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 132
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 131
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 130
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 130
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 130
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 129
Prognostic factors for hepatocellular carcinoma recurrence 129
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 128
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 128
Gut microbiota and its pathophysiology in disease paradigms. 128
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 127
Bacteria flora,gas and antibiotics 127
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 127
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 125
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 125
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 124
Gut microbiota and metabolic syndrome. 123
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. 123
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 123
Ecosistema intestinale: aspetti fisiopatologici e terapeutici 122
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, costipation-variant: results of a multicenter trial 121
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. 121
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 121
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 121
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 120
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 120
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 119
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 119
Salivary TUDCA concentration profiles after TUDCA oral load: a non-invasive test for intestinal transit time evaluation 118
null 117
Italian consensus conference for colonic diverticulosis and diverticular disease 116
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 115
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 115
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 114
Transient Elastography (FibroScan) Is Not Correlated with Liver Fibrosis but with Cholestasis in Patients with Long-Term Home Parenteral Nutrition 114
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 113
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 113
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 112
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 111
Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease 111
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 111
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 110
Totale 14.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.185 0 0 0 0 0 77 25 96 177 81 83 646
2021/20222.583 241 119 139 156 211 143 60 119 88 149 771 387
2022/20232.529 286 355 158 324 162 195 52 134 454 61 176 172
2023/2024640 38 114 38 72 43 150 23 51 35 31 22 23
2024/20252.451 94 450 223 158 481 127 144 56 33 184 59 442
2025/20262.422 362 414 475 389 599 183 0 0 0 0 0 0
Totale 17.438